Streetbeat News

Products Services

DKNG

PARA

PARAA

The 2023 NFL season has been simulated using the Madden 24 video game by Electronic Arts Inc (NASDAQ:EA), predicting the playoffs, Super Bowl LVIII, and award winners. The simulation predicts the Kansas City Chiefs beating the Tampa Bay Buccaneers in the Super Bowl. Betting odds for various outcomes have been provided by DraftKings Inc (NASDAQ:DKNG). The Super Bowl will be aired on CBS and Nickelodeon and streamed on Paramount+, all units of Paramount Global (NASDAQ:PARA)(NASDAQ:PARAA).

Portfolio Pulse from Chris Katje

August 28, 2023 | 9:04 pm

MSFT

OpenAI, backed by Microsoft Corp. (NASDAQ:MSFT), has launched ChatGPT Enterprise, a corporate-focused AI chatbot. The new product promises enhanced data encryption and user data privacy. Companies such as Estée Lauder Cos. (NYSE:EL), Canva, and Zapier have already adopted the technology. OpenAI has pledged not to use enterprise data to train its AI models to address data security concerns.

Portfolio Pulse from Piero Cingari

August 28, 2023 | 8:57 pm

GOOG

MAR

PCG

TSLA

Google plans to sell new mapping APIs to companies building products around renewable energy, with the aim of generating up to $100 million in its first year. Potential customers include Zillow, Marriott, Tesla, PG&E, SunRun, and Aurora Solar. The data will come from Project Sunroof, a solar savings calculator launched in 2015. Google also plans to launch an Air Quality API. This move is part of Google's strategy to monetize its maps products and tap into the sustainability market.

Portfolio Pulse from Happy Mohamed

August 28, 2023 | 8:35 pm

AMZN

ATVI

Amazon Prime Gaming subscribers can now get a $15 'Call of Duty' bundle for free as part of the August and September rewards. The bundle includes various cosmetics that can be used in 'Call of Duty: Modern Warfare 2', 'Call of Duty: Warzone', and 'Call of Duty: Modern Warfare 3'. This is the second bundle in the World Series of Warzone promotion, suggesting more bundles in the future. Activision Blizzard has also announced that content acquired in Modern Warfare 2 will carry over to Modern Warfare 3.

Portfolio Pulse from Franca Quarneti

August 28, 2023 | 8:34 pm

PLRX

Pliant Therapeutics has announced three presentations at the European Respiratory Society International Congress 2023. The presentations will cover the inhibitor bexotegrast's impact on fibrogenesis in the human lung, its safety and antifibrotic activity from a Phase 2a study, and the elevated levels of circulating ITGB6 in patients with IPF.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 8:30 pm

DBX

PTON

VLVLY

Peloton Interactive Inc (NASDAQ:PTON) reported a wider-than-expected loss and a quarterly drop in subscribers due to a costly bike recall, causing shares to plunge 22%. Despite this, sales were above expectations at $642.1 million. The company is focusing on rebranding and expanding, with new partnerships and initiatives, including a business-to-business offer and a school initiative with the University of Michigan. Companies such as AB Volvo (OTC:VLVLY) and Dropbox Inc (NASDAQ:DBX) are already clients.

Portfolio Pulse from Upwallstreet

August 28, 2023 | 8:18 pm

JNJ

Janssen, a subsidiary of Johnson & Johnson (JNJ), has submitted a supplemental New Drug Application to the FDA for full approval of Balversa. The drug is intended for the treatment of patients with locally advanced or metastatic urothelial carcinoma and selected fibroblast growth factor receptor gene alterations.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 8:16 pm

GLPG

Galapagos has announced the initiation of the GALACELA Phase 2 trial for Systemic Lupus Erythematosus (SLE) with GLPG3667. The first patient has been randomized in the trial.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2023 | 8:16 pm

PARA

An unofficial video game with PlayStation 1 graphics, based on the series 'Twin Peaks', has been released. The series is currently available to watch on Paramount Global's (NASDAQ:PARA) Paramount+. The game, called 'Into The Night', is still under development and is available for free download on Itch.io.

Portfolio Pulse from El Planteo

August 28, 2023 | 8:12 pm

ENVB

Enveric Biosciences (NASDAQ:ENVB) has been granted a US patent for its lead candidate EB-373, a psilocin prodrug under development for the treatment of anxiety disorder. The patent covers compositions and methods for tryptamine-derived prodrugs. The company believes these enhancements could provide a more rapid onset of action and reduced side effects compared to traditional psilocin prodrugs. Enveric is also advancing EVM201 and EVM301 series towards creating innovative alterations to related compounds for treating critical mental health disorders.

Portfolio Pulse from Lara Goldstein

August 28, 2023 | 8:08 pm